Sanoviv Treats Parkinson’s Disease, Diagnoses PD Symptoms and Provides Parkinson’s Treatments including CCSVI
According to the US National Parkinson’s Foundation, each person living with PD spends an average of $2,500 a year for medications. The total cost is estimated to exceed $5.6 billion annually. About 50,000 Americans are diagnosed with Parkinson’s disease each year, with more than half a million Americans affected at any time.
Sanoviv excels at finding the root cause of Parkinson’s disease symptoms and at treating auto-immune and chronic degenerative diseases. Our “whole body,” nutrition-based approach and advanced medical treatments allow us to view each patient as a whole person rather than just a series of symptoms and diseases.
In 2010, Sanoviv began offering CCSVI diagnosis and treatment to people living with PD, as well as Multiple Sclerosis and other neurological illnesses. Studies have found that stenosis, or narrowing, of neck veins may not adequately drain cellular wastes from the brain. If cellular wastes, particularly iron deposits, remain in the brain they have the potential to erode the myelin sheath around nerves. Dangerous levels of iron deposits are often found in PD patients’ brains, leading to the hypothesis that CCSVI may contribute to PD symptoms.
For more information on Sanoviv’s approach to neurological conditions, please learn more and contact Sanoviv here.